...
首页> 外文期刊>Journal of chromatography, A: Including electrophoresis and other separation methods >Liquid chromatographic determination of enrofloxacin in nasal secretions and plasma of healthy pigs using restricted access material for on-line sample clean-up
【24h】

Liquid chromatographic determination of enrofloxacin in nasal secretions and plasma of healthy pigs using restricted access material for on-line sample clean-up

机译:液相色谱法测定健康猪鼻腔分泌物中血浆恩诺沙星的含量

获取原文
获取原文并翻译 | 示例
           

摘要

A new fully automated method was developed for the quantitative analysis of an antibacterial drug, enrofloxacin (ENRO), in both nasal secretions and plasma samples of healthy pigs. The method is based on the use of a pre-column packed with restricted access material (RAM), namely R-P-18 ADS (alkyl diol silica), for on-line sample clean-up coupled to a liquid chromatographic (LC) column containing octadecyl silica. The only off-line sample preparation was the 50-fold dilution of nasal secretions and plasma samples in the washing liquid composed of 25 mM phosphate buffer of pH 7.4. A 10 mu l diluted sample volume was injected directly onto the pre-column and washed for 7 min. By rotation of a switching valve, the analyte of interest was eluted in the back-flush mode with the LC mobile phase which consisted in a mixture of 25 mM phosphate buffer of pH 3.0 and acetonitrile according to a segmented gradient elution. By a new rotation of the switching valve, the pre-column and the analytical column were equilibrated for 3 min with the initial mobile phases. The flow-rate was 0.8 ml min(-1) for the washing liquid and 1.5 ml min(-1) for the LC mobile phase. ENRO was detected by fluorescence at excitation and emission wavelengths of 278 and 445 nm, respectively. Finally, the developed method was validated using an original strategy based on total measurement error and accuracy profiles as a decision tool. The limits of quantitation of ENRO in plasma and in nasal secretions were 30.5 and 91.6 ng/ml, respectively. The validated method was then applied successfully to the determination of ENRO in healthy pigs treated by intramuscular injection at different doses (2.5, 10 and 30 mg/kg bodyweight) for a pilot study. This method could be also used for the simultaneous analysis of ENRO and its main metabolite, ciprofloxacin (CIPRO). (c) 2007 Elsevier B.V. All rights reserved.
机译:开发了一种新型的全自动方法,用于定量分析健康猪的鼻分泌物和血浆样品中的抗菌药物恩诺沙星(ENRO)。该方法基于使用填充有受限访问材料(RAM)的预柱,即RP-18 ADS(烷基二醇硅石)进行在线样品净化,并与包含以下成分的液相色谱(LC)色谱柱耦合十八烷基二氧化硅。唯一的离线样品制备方法是在由25 mM pH 7.4的磷酸盐缓冲液组成的洗涤液中将鼻分泌液和血浆样品稀释50倍。将10μl稀释的样品体积直接注入到预柱中,并洗涤7分钟。通过切换阀的旋转,用LC流动相在反吹模式下洗脱目标分析物,LC流动相根据分段梯度洗脱法,由25 mM pH 3.0的磷酸盐缓冲液和乙腈组成。通过切换阀的新旋转,使预柱和分析柱与初始流动相平衡3分钟。洗涤液的流速为0.8 ml min(-1),LC流动相的流速为1.5 ml min(-1)。通过激发和发射波长分别为278和445 nm的荧光检测到ENRO。最后,使用基于总测量误差和精度曲线的原始策略作为决策工具对开发的方法进行了验证。血浆和鼻分泌物中ENRO的定量限分别为30.5和91.6 ng / ml。然后,已验证的方法成功地用于测定不同剂量(2.5、10和30 mg / kg体重)的肌肉注射治疗的健康猪中的ENRO,以进行初步研究。该方法还可用于同时分析ENRO及其主要代谢产物环丙沙星(CIPRO)。 (c)2007 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号